GotoBiopharm
About GoToBiopharm
GoToBiopharm (Hubei Goto Biopharm Co., Ltd.) is a high-tech enterprise specializing in the research, production, and supply of steroid drug starting materials, key intermediates, and active pharmaceutical ingredients (APIs). Founded in 2006 and headquartered in Xiangyang City, Hubei Province, the company was listed on the Shenzhen Stock Exchange Growth Enterprise Board in 2021 (stock code: 300966.SZ).
GoToBiopharm is recognized as one of the largest suppliers of steroid starting materials in China and holds a strong position in the upstream and midstream segments of the steroid industry chain.
Core Strengths
- Leading producer of steroid starting materials, intermediates, and APIs
- Vertically integrated capabilities across corticosteroid, sex hormone, and progestogen intermediates
- Manufacturing technologies include chemical synthesis and bioconversion
- GMP-compliant facilities and a robust EHS (Environment, Health & Safety) system
- Two dedicated high-end R&D centers supporting technical development and CDMO projects
Product Portfolio
- DHEA and DHEA micronized
- Plant-based Cholesterol
- Plant-based Vitamin D3
- Plant-based 25-hydroxy Vitamin D3
- Plant-based UDCA (Ursodeoxycholic Acid)
- Plant-based TUDCA (Tauroursodeoxycholic Acid)
CDMO & Custom Services
GoToBiopharm offers Steroid CDMO services and customized steroid product development, leveraging its advanced manufacturing infrastructure and R&D capabilities to support customer-specific requirements.
With a focus on quality, technical strength, and reliable supply, GoToBiopharm serves as a strategic partner for companies seeking high-quality steroid intermediates and plant-based APIs.